Elevai Labs, Inc. (ELAB)
- Previous Close
0.5730 - Open
0.5710 - Bid --
- Ask --
- Day's Range
0.5710 - 0.6000 - 52 Week Range
0.5710 - 4.2440 - Volume
14,204 - Avg. Volume
697,462 - Market Cap (intraday)
10.138M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
elevaiskincare.comRecent News: ELAB
Performance Overview: ELAB
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELAB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELAB
Valuation Measures
Market Cap
10.14M
Enterprise Value
7.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.67
Price/Book (mrq)
2.65
Enterprise Value/Revenue
4.10
Enterprise Value/EBITDA
-1.64
Financial Highlights
Profitability and Income Statement
Profit Margin
-251.17%
Return on Assets (ttm)
-64.76%
Return on Equity (ttm)
-173.51%
Revenue (ttm)
1.71M
Net Income Avi to Common (ttm)
-4.3M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
3.33M
Total Debt/Equity (mrq)
5.50%
Levered Free Cash Flow (ttm)
-2.34M
Research Analysis: ELAB
Analyst Price Targets
No Analyst Price Targets available for this ticker